Market Overview:
The global internal radiotherapy devices market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, technological advancements in radiotherapy devices, and rising demand for minimally invasive treatments. The global internal radiotherapy devices market is segmented by type into HDR afterloaders and PDR afterloaders. The HDR afterloader segment is expected to grow at a CAGR of 6% from 2018 to 2030, while the PDR afterloader segment is expected to grow at a CAGR of 4% from 2018 to 2030. On the basis of application, the global internal radiotherapy devices market is divided into prostate cancer, gynecological cancer, breast cancer, and other applications. The prostate cancer segment accounted for the largest share (36%) of the global internal radiotherapy devices market in 2017 and it is projected to maintain its dominance during the forecast period owing to rising incidence rates globally. However, with increasing awareness about early detection and treatment options for various types of cancers among women across regions such as Asia Pacific and Latin America;the gynecological cancer segmentis projectedto registerthe highestCAGRof 7%.
Product Definition:
Internal radiotherapy devices are used to deliver radiation therapy directly to the tumor. This can be done by inserting a device into the tumor or by implanting a radioactive source near the tumor. Internal radiotherapy is used to treat many types of cancer, including brain tumors, liver tumors, and pancreatic tumors.
HDR Afterloaders:
High-Density Polyethylene (HDPE) or Afterloaders as it is commonly known, is a type of plastic used in the manufacturing of HDR afterloaders. It has high mechanical strength and low density making it ideal for use in medical devices.
PDR Afterloaders:
PDR Afterloaders is a device used to reduce the dose of radiation to the heart and lungs. It works by reducing the amount of x-ray exposure to patients, as it was shown to decrease Varian's SARS-CoV-2 treatment dosage by 50%.
The market for PDR afterloaders is expected to grow at a lucrative rate during the forecast period owing its benefits in reducing radiation damage which leads towards reduced side effects and improved effectiveness.
Application Insights:
The other application segment includes lung cancer, bone metastasis, head and neck cancer, skin metastasis and others. Breast cancer is estimated to be the fastest-growing application segment over the forecast period owing to increasing awareness about early detection of breast tumor. HDR afterloaders are used for external beam radiation therapy in the treatment of breast carcinoma.
External beam radiation therapy is used for treating a large number of patients with breast carcinoma as it allows precise dosage to targeted areas which cannot be achieved with internal radiation therapy devices such as brachytherapy machines or image-guided robots due to their size constraints. HDR afterloaders can also treat prostate cancer since they have been designed specifically for this purpose along with being able to deliver proton beams which are highly effective in killing prostate tumor cells without causing any damage on surrounding healthy tissues resulting in fewer side effects compared to conventional treatments such as robot-assisted EBRT or LDRT using cesium rays.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high adoption rate of technologically advanced products and increasing government initiatives. Moreover, rising incidence rates of cancer is also expected to boost demand for radiotherapy devices in this region. For instance, as per American Cancer Society (ACS), Inc., around 2 million new cases will be diagnosed in the U.S.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period due to factors such as improving healthcare facilities & infrastructure coupled with growing awareness about available treatment options especially for off-shore diseases like breast cancer or brain tumor which are not so common here than other parts of world thus creating huge market potentials for HDR afterloaders system.
Growth Factors:
- Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for internal radiotherapy devices in the coming years.
- Technological advancements: The internal radiotherapy devices market is witnessing rapid technological advancements, which is resulting in the development of innovative and advanced products. This is likely to boost the growth of this market in the near future.
- Rising awareness about radiation therapy: There has been a rise in awareness about radiation therapy among patients and healthcare professionals alike over the past few years. This is likely to propel demand for internal radiotherapy devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Internal Radiotherapy Devices Market Research Report
By Type
HDR Afterloaders, PDR Afterloaders
By Application
Prostate Cancer, Gynecological Cancer, Breast Cancer, Other
By Companies
Varian, Eckert and Zieglar BEBIG, Elekta
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Internal Radiotherapy Devices Market Report Segments:
The global Internal Radiotherapy Devices market is segmented on the basis of:
Types
HDR Afterloaders, PDR Afterloaders
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Prostate Cancer, Gynecological Cancer, Breast Cancer, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Varian
- Eckert and Zieglar BEBIG
- Elekta
Highlights of The Internal Radiotherapy Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HDR Afterloaders
- PDR Afterloaders
- By Application:
- Prostate Cancer
- Gynecological Cancer
- Breast Cancer
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Internal Radiotherapy Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Internal radiotherapy devices are used to deliver radiation therapy to the body within the body. They include implants such as brachytherapy seeds and rods, and external devices such as linear accelerators or radiosurgery machines.
Some of the key players operating in the internal radiotherapy devices market are Varian, Eckert and Zieglar BEBIG, Elekta.
The internal radiotherapy devices market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Internal Radiotherapy Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Internal Radiotherapy Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Internal Radiotherapy Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Internal Radiotherapy Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Internal Radiotherapy Devices Market Size & Forecast, 2020-2028
4.5.1 Internal Radiotherapy Devices Market Size and Y-o-Y Growth
4.5.2 Internal Radiotherapy Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 HDR Afterloaders
5.2.2 PDR Afterloaders
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Prostate Cancer
6.2.2 Gynecological Cancer
6.2.3 Breast Cancer
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Internal Radiotherapy Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Internal Radiotherapy Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 HDR Afterloaders
9.6.2 PDR Afterloaders
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Prostate Cancer
9.10.2 Gynecological Cancer
9.10.3 Breast Cancer
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 HDR Afterloaders
10.6.2 PDR Afterloaders
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Prostate Cancer
10.10.2 Gynecological Cancer
10.10.3 Breast Cancer
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 HDR Afterloaders
11.6.2 PDR Afterloaders
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Prostate Cancer
11.10.2 Gynecological Cancer
11.10.3 Breast Cancer
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 HDR Afterloaders
12.6.2 PDR Afterloaders
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Prostate Cancer
12.10.2 Gynecological Cancer
12.10.3 Breast Cancer
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 HDR Afterloaders
13.6.2 PDR Afterloaders
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Prostate Cancer
13.10.2 Gynecological Cancer
13.10.3 Breast Cancer
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Internal Radiotherapy Devices Market: Competitive Dashboard
14.2 Global Internal Radiotherapy Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Varian
14.3.2 Eckert and Zieglar BEBIG
14.3.3 Elekta
